
The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: A systematic review of reviews
Author(s) -
Pradeep Paul George,
Joseph Antonio DeCastro Molina,
Bee Hoon Heng
Publication year - 2014
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.138615
Subject(s) - medicine , macular degeneration , pegaptanib , bevacizumab , systematic review , medline , critical appraisal , checklist , quality score , meta analysis , data extraction , inclusion and exclusion criteria , ophthalmology , ranibizumab , surgery , alternative medicine , pathology , psychology , metric (unit) , operations management , chemotherapy , political science , law , economics , cognitive psychology
To systematically collate and evaluate the evidence from recent SRs of bevacizumab for neo-vascular age related macular degeneration.